Central Texas TX

Aeglea BioTherapeutics Announces Presentation of Seven Abstracts at ICIEM 2021 Including Oral Presentation of PEACE Study Baseline Characteristics

Brenham Banner Press

Nov 4, 2021

AUSTIN, Texas, Nov. 4, 2021 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. (Nasdaq: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeu…

Read the full story at Brenham Banner Press

Related places

Brenham Austin

Aeglea BioTherapeutics Announces Presentation of Seven Abstracts at ICIEM 2021 Including Oral Presentation of PEACE Study Baseline Characteristics

Related places

More from Central Texas

Buda marks 25 years of economic development with larger than life weiner dog sculpture

Austin city council candidates face voters at accountability forum ahead of elections

Houdini Lecture and Magic Show come to Austin College

Families, LULAC rally at Texas Capitol seeking accountability in Xavier Hernandez death

Centex roundup: Belton fends off Waco High, Vanguard overwhelms No. 8 Lucas Christian

Women's Golf in First after round one of the Golfweek October Classic

Mills County Judge's Report

Eagles lose edge Nolan Smith to concussion